Webcast on Friday September 26 2014 at 830 a.m. Eastern Time Esperion Therapeutics Inc. NASDAQ ESPR a clinicalstage emerging pharmaceutical company focused on developing and commercializing firstinclass oral lowdensity lipoprotei...
↧